Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.4B | 6.0B | 4.3B | 4.5B |
Cost of revenue | 2.6B | — | — | 2.5B |
Gross profit | 1.8B | — | — | 1.9B |
Operating expense | ||||
Research & development | 1.1B | 1.1B | 1.1B | 1.1B |
Selling general and admin | 728M | 789M | 692M | 715M |
Other operating expenses | -1M | — | — | -345M |
Operating income | -48M | 490M | 246M | 432M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 1M | — | — | 3M |
Pretax income | -36M | 1.1B | 145M | 461M |
Tax provision | 23M | — | — | 92M |
Net income | -60M | 813M | 175M | -142M |
Basic EPS | 0.0 | 0.2 | 0.0 | 0.0 |
Diluted EPS | 0.0 | 0.2 | 0.0 | 0.0 |
Basic average shares | 4.7B | 4.8B | 4.8B | 4.8B |
Diluted average shares | 4.7B | 4.8B | 5.1B | 4.9B |
EBITDA | 216M | 1.3B | 246M | 700M |
Net income from continuing op. | -60M | — | — | -142M |
Minority interests | 0 | — | — | -3M |
Preferred stock dividends | — | — | — | — |